Meitav Investment House’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-36,200
Closed -$1.83M 389
2019
Q4
$1.83M Buy
36,200
+1,300
+4% +$67.1K 0.13% 93
2019
Q3
$1.66M Buy
34,900
+200
+0.6% +$9.13K 0.12% 100
2019
Q2
$1.62M Buy
34,700
+700
+2% +$32.3K 0.11% 110
2019
Q1
$1.63M Buy
34,000
+8,890
+35% +$445K 0.09% 132
2018
Q4
$1.12M Buy
25,110
+5,496
+28% +$286K 0.07% 139
2018
Q3
$1.06M Sell
19,614
-1,090
-5% -$55.8K 0.05% 201
2018
Q2
$1.02M Buy
20,704
+1,529
+8% +$86.7K 0.05% 200
2018
Q1
$1.2M Buy
19,175
+13,175
+220% +$904K 0.06% 136
2017
Q4
$373K Buy
+6,000
New +$371K 0.02% 170

Other funds holding CAH

Meitav Investment House's CAH Position: Q1 2020 in Review

Meitav Investment House sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 36,200 shares — an estimated $1.83M sold.

Meitav Investment House first reported a position in CAH in Q4 2017 and held it in 9 quarters. The position peaked at $1.83M in Q4 2019. 721 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

  • Meitav Investment House reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
  • Meitav Investment House sold 36,200 Cardinal Health shares in Q1 2020, an estimated $1.83M.
  • Meitav Investment House first reported a position in Cardinal Health in Q4 2017 and held it in 9 quarters.
  • Meitav Investment House's Cardinal Health position peaked at $1.83M in Q4 2019.
  • 721 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on Meitav Investment House's 13F filing for Q1 2020, filed 11 May 2020.